Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Patent blue

2

X.f Anaphylaxis-Anaphylactoid reaction (can be fatal)

2
Last update : 10/09/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Anaphylactic reaction to patent blue V used in preoperative computed tomography-guided dye localization of small lung nodules.
Journal of the Formosan Medical Association = Taiwan yi zhi 2016 Apr;115;288-9 2016 Apr
Anaphylaxis to Patent Blue V: a case series.
Asia Pacific allergy 2012 Jan;2;86-9 2012 Jan
Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol.
Allergy 2010 Mar;65;396-400 2010 Mar
Investigation of anaphylactic reaction after patent blue V dye injection.
Breast (Edinburgh, Scotland) 2010 Dec;19;516-20 2010 Dec
[Anaphylactic shock due to patent blue: four case report and review of literature].
Journal de gynecologie, obstetrique et biologie de la reproduction 2010 Apr;39;116-20 2010 Apr
Anaphylactic reaction to patent blue V after sentinel lymph node biopsy.
Acta anaesthesiologica Scandinavica 2006 Feb;50;245-7 2006 Feb
Near-fatal anaphylaxis to patent blue V.
The British journal of dermatology 2004 May;150;1037-8 2004 May
Anaphylaxis to patent blue during sentinel lymph node biopsy.
ANZ journal of surgery 2004 Jul;74;607-8 2004 Jul

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies